img

Global Autoimmune Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Autoimmune Disease Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Autoimmune disease is a condition in which the immune system is unable to recognize the body’s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well as improper functioning of body organs.
Autoimmune Disease Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Autoimmune Disease Drug market is projected to reach US$ 10220 million in 2029, increasing from US$ 6080 million in 2022, with the CAGR of 7.6% during the period of 2024 to 2029. Demand from Rheumatoid Arthritis and Type 1 Diabetes are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Autoimmune Disease Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
GlaxoSmithKline
Roche
Biogen
Amgen
Segment by Type
NSAIDs
Anti-Inflammatory
Interferons
Antihyperglycemics
Others

Segment by Application


Rheumatoid Arthritis
Type 1 Diabetes
Multiple Sclerosis
Psoriasis
Lupus
Inflammatory Bowel Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Autoimmune Disease Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Autoimmune Disease Drug introduction, etc. Autoimmune Disease Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Autoimmune Disease Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Autoimmune Disease Drug
1.1 Autoimmune Disease Drug Market Overview
1.1.1 Autoimmune Disease Drug Product Scope
1.1.2 Autoimmune Disease Drug Market Status and Outlook
1.2 Global Autoimmune Disease Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Autoimmune Disease Drug Market Size by Region (2018-2029)
1.4 Global Autoimmune Disease Drug Historic Market Size by Region (2018-2024)
1.5 Global Autoimmune Disease Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Autoimmune Disease Drug Market Size (2018-2029)
1.6.1 North America Autoimmune Disease Drug Market Size (2018-2029)
1.6.2 Europe Autoimmune Disease Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Autoimmune Disease Drug Market Size (2018-2029)
1.6.4 Latin America Autoimmune Disease Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Autoimmune Disease Drug Market Size (2018-2029)
2 Autoimmune Disease Drug Market by Type
2.1 Introduction
2.1.1 NSAIDs
2.1.2 Anti-Inflammatory
2.1.3 Interferons
2.1.4 Antihyperglycemics
2.1.5 Others
2.2 Global Autoimmune Disease Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Autoimmune Disease Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Autoimmune Disease Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Autoimmune Disease Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Autoimmune Disease Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Autoimmune Disease Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Autoimmune Disease Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Autoimmune Disease Drug Revenue Breakdown by Type (2018-2029)
3 Autoimmune Disease Drug Market Overview by Application
3.1 Introduction
3.1.1 Rheumatoid Arthritis
3.1.2 Type 1 Diabetes
3.1.3 Multiple Sclerosis
3.1.4 Psoriasis
3.1.5 Lupus
3.1.6 Inflammatory Bowel Disease
3.1.7 Others
3.2 Global Autoimmune Disease Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Autoimmune Disease Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Autoimmune Disease Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Autoimmune Disease Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Autoimmune Disease Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Autoimmune Disease Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Autoimmune Disease Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Autoimmune Disease Drug Revenue Breakdown by Application (2018-2029)
4 Autoimmune Disease Drug Competition Analysis by Players
4.1 Global Autoimmune Disease Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Disease Drug as of 2022)
4.3 Date of Key Players Enter into Autoimmune Disease Drug Market
4.4 Global Top Players Autoimmune Disease Drug Headquarters and Area Served
4.5 Key Players Autoimmune Disease Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Autoimmune Disease Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Autoimmune Disease Drug Products, Services and Solutions
5.1.4 Abbott Laboratories Autoimmune Disease Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Abbott Laboratories Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Autoimmune Disease Drug Products, Services and Solutions
5.2.4 Pfizer Autoimmune Disease Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Pfizer Recent Developments
5.3 AbbVie
5.3.1 AbbVie Profile
5.3.2 AbbVie Main Business
5.3.3 AbbVie Autoimmune Disease Drug Products, Services and Solutions
5.3.4 AbbVie Autoimmune Disease Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Eli Lilly Recent Developments
5.4 Eli Lilly
5.4.1 Eli Lilly Profile
5.4.2 Eli Lilly Main Business
5.4.3 Eli Lilly Autoimmune Disease Drug Products, Services and Solutions
5.4.4 Eli Lilly Autoimmune Disease Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Eli Lilly Recent Developments
5.5 Bristol-Myers Squibb
5.5.1 Bristol-Myers Squibb Profile
5.5.2 Bristol-Myers Squibb Main Business
5.5.3 Bristol-Myers Squibb Autoimmune Disease Drug Products, Services and Solutions
5.5.4 Bristol-Myers Squibb Autoimmune Disease Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Bristol-Myers Squibb Recent Developments
5.6 AstraZeneca plc
5.6.1 AstraZeneca plc Profile
5.6.2 AstraZeneca plc Main Business
5.6.3 AstraZeneca plc Autoimmune Disease Drug Products, Services and Solutions
5.6.4 AstraZeneca plc Autoimmune Disease Drug Revenue (US$ Million) & (2018-2024)
5.6.5 AstraZeneca plc Recent Developments
5.7 GlaxoSmithKline
5.7.1 GlaxoSmithKline Profile
5.7.2 GlaxoSmithKline Main Business
5.7.3 GlaxoSmithKline Autoimmune Disease Drug Products, Services and Solutions
5.7.4 GlaxoSmithKline Autoimmune Disease Drug Revenue (US$ Million) & (2018-2024)
5.7.5 GlaxoSmithKline Recent Developments
5.8 Roche
5.8.1 Roche Profile
5.8.2 Roche Main Business
5.8.3 Roche Autoimmune Disease Drug Products, Services and Solutions
5.8.4 Roche Autoimmune Disease Drug Revenue (US$ Million) & (2018-2024)
5.8.5 Roche Recent Developments
5.9 Biogen
5.9.1 Biogen Profile
5.9.2 Biogen Main Business
5.9.3 Biogen Autoimmune Disease Drug Products, Services and Solutions
5.9.4 Biogen Autoimmune Disease Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Biogen Recent Developments
5.10 Amgen
5.10.1 Amgen Profile
5.10.2 Amgen Main Business
5.10.3 Amgen Autoimmune Disease Drug Products, Services and Solutions
5.10.4 Amgen Autoimmune Disease Drug Revenue (US$ Million) & (2018-2024)
5.10.5 Amgen Recent Developments
6 North America
6.1 North America Autoimmune Disease Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Autoimmune Disease Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Autoimmune Disease Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Autoimmune Disease Drug Market Dynamics
11.1 Autoimmune Disease Drug Industry Trends
11.2 Autoimmune Disease Drug Market Drivers
11.3 Autoimmune Disease Drug Market Challenges
11.4 Autoimmune Disease Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Autoimmune Disease Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Autoimmune Disease Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Autoimmune Disease Drug Market Size Share by Region (2018-2024)
Table 4. Global Autoimmune Disease Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Autoimmune Disease Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Autoimmune Disease Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Autoimmune Disease Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Autoimmune Disease Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Autoimmune Disease Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Autoimmune Disease Drug Revenue Market Share by Type (2024-2029)
Table 11. North America Autoimmune Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Autoimmune Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Autoimmune Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Autoimmune Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Autoimmune Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Autoimmune Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Autoimmune Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Autoimmune Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Autoimmune Disease Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Autoimmune Disease Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Autoimmune Disease Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Autoimmune Disease Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Autoimmune Disease Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Autoimmune Disease Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Autoimmune Disease Drug Revenue Market Share by Application (2024-2029)
Table 26. North America Autoimmune Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Autoimmune Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Autoimmune Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Autoimmune Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Autoimmune Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Autoimmune Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Autoimmune Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Autoimmune Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Autoimmune Disease Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Autoimmune Disease Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Autoimmune Disease Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Autoimmune Disease Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Disease Drug as of 2022)
Table 39. Date of Key Players Enter into Autoimmune Disease Drug Market
Table 40. Global Autoimmune Disease Drug Key Players Headquarters and Area Served
Table 41. Autoimmune Disease Drug Product Solution and Service
Table 42. Global Autoimmune Disease Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Abbott Laboratories Basic Information List
Table 45. Abbott Laboratories Description and Business Overview
Table 46. Abbott Laboratories Autoimmune Disease Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Autoimmune Disease Drug Business of Abbott Laboratories (2018-2024)
Table 48. Abbott Laboratories Recent Developments
Table 49. Pfizer Basic Information List
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Autoimmune Disease Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Autoimmune Disease Drug Business of Pfizer (2018-2024)
Table 53. Pfizer Recent Developments
Table 54. AbbVie Basic Information List
Table 55. AbbVie Description and Business Overview
Table 56. AbbVie Autoimmune Disease Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Autoimmune Disease Drug Business of AbbVie (2018-2024)
Table 58. AbbVie Recent Developments
Table 59. Eli Lilly Basic Information List
Table 60. Eli Lilly Description and Business Overview
Table 61. Eli Lilly Autoimmune Disease Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Autoimmune Disease Drug Business of Eli Lilly (2018-2024)
Table 63. Eli Lilly Recent Developments
Table 64. Bristol-Myers Squibb Basic Information List
Table 65. Bristol-Myers Squibb Description and Business Overview
Table 66. Bristol-Myers Squibb Autoimmune Disease Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Autoimmune Disease Drug Business of Bristol-Myers Squibb (2018-2024)
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. AstraZeneca plc Basic Information List
Table 70. AstraZeneca plc Description and Business Overview
Table 71. AstraZeneca plc Autoimmune Disease Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Autoimmune Disease Drug Business of AstraZeneca plc (2018-2024)
Table 73. AstraZeneca plc Recent Developments
Table 74. GlaxoSmithKline Basic Information List
Table 75. GlaxoSmithKline Description and Business Overview
Table 76. GlaxoSmithKline Autoimmune Disease Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Autoimmune Disease Drug Business of GlaxoSmithKline (2018-2024)
Table 78. GlaxoSmithKline Recent Developments
Table 79. Roche Basic Information List
Table 80. Roche Description and Business Overview
Table 81. Roche Autoimmune Disease Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Autoimmune Disease Drug Business of Roche (2018-2024)
Table 83. Roche Recent Developments
Table 84. Biogen Basic Information List
Table 85. Biogen Description and Business Overview
Table 86. Biogen Autoimmune Disease Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Autoimmune Disease Drug Business of Biogen (2018-2024)
Table 88. Biogen Recent Developments
Table 89. Amgen Basic Information List
Table 90. Amgen Description and Business Overview
Table 91. Amgen Autoimmune Disease Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Autoimmune Disease Drug Business of Amgen (2018-2024)
Table 93. Amgen Recent Developments
Table 94. North America Autoimmune Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 95. North America Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 96. Europe Autoimmune Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 97. Europe Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 98. Asia-Pacific Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Asia-Pacific Autoimmune Disease Drug Market Size by Region (2018-2024) & (US$ Million)
Table 100. Asia-Pacific Autoimmune Disease Drug Market Size by Region (2024-2029) & (US$ Million)
Table 101. Asia-Pacific Autoimmune Disease Drug Market Share by Region (2018-2024)
Table 102. Asia-Pacific Autoimmune Disease Drug Market Share by Region (2024-2029)
Table 103. Latin America Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Latin America Autoimmune Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 105. Latin America Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 106. Middle East & Africa Autoimmune Disease Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2018-2024) & (US$ Million)
Table 108. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2024-2029) & (US$ Million)
Table 109. Autoimmune Disease Drug Market Trends
Table 110. Autoimmune Disease Drug Market Drivers
Table 111. Autoimmune Disease Drug Market Challenges
Table 112. Autoimmune Disease Drug Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Autoimmune Disease Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Autoimmune Disease Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global Autoimmune Disease Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Autoimmune Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Autoimmune Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Autoimmune Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Autoimmune Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Autoimmune Disease Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of NSAIDs
Figure 11. Global NSAIDs Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Anti-Inflammatory
Figure 13. Global Anti-Inflammatory Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Interferons
Figure 15. Global Interferons Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Antihyperglycemics
Figure 17. Global Antihyperglycemics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Global Autoimmune Disease Drug Market Size Share by Type: 2022 & 2029
Figure 21. North America Autoimmune Disease Drug Revenue Market Share by Type (2018-2029)
Figure 22. Europe Autoimmune Disease Drug Revenue Market Share by Type (2018-2029)
Figure 23. Asia-Pacific Autoimmune Disease Drug Revenue Market Share by Type (2018-2029)
Figure 24. Latin America Autoimmune Disease Drug Revenue Market Share by Type (2018-2029)
Figure 25. Middle East and Africa Autoimmune Disease Drug Revenue Market Share by Type (2018-2029)
Figure 26. Rheumatoid Arthritis Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Type 1 Diabetes Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Multiple Sclerosis Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 29. Psoriasis Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 30. Lupus Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 31. Inflammatory Bowel Disease Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 32. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 33. Global Autoimmune Disease Drug Market Size Share by Application: 2022 & 2029
Figure 34. North America Autoimmune Disease Drug Revenue Market Share by Application (2018-2029)
Figure 35. Europe Autoimmune Disease Drug Revenue Market Share by Application (2018-2029)
Figure 36. Asia-Pacific Autoimmune Disease Drug Revenue Market Share by Application (2018-2029)
Figure 37. Latin America Autoimmune Disease Drug Revenue Market Share by Application (2018-2029)
Figure 38. Middle East and Africa Autoimmune Disease Drug Revenue Market Share by Application (2018-2029)
Figure 39. Autoimmune Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 40. Global Top 5 and Top 10 Players Autoimmune Disease Drug Market Share in 2022
Figure 41. North America Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 42. United States Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 43. Canada Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 44. Germany Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 45. France Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 46. U.K. Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 47. Italy Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 48. Russia Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 49. Nordic Countries Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 50. Asia-Pacific Autoimmune Disease Drug Market Share by Region (2018-2029)
Figure 51. China Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 52. Japan Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 53. South Korea Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 54. Southeast Asia Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 55. India Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 56. Australia Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 57. Latin America Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 58. Mexico Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 59. Brazil Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 60. Middle East & Africa Autoimmune Disease Drug Market Share by Country (2018-2029)
Figure 61. Turkey Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 62. Saudi Arabia Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 63. UAE Autoimmune Disease Drug Market Size (2018-2029) & (US$ Million)
Figure 64. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries